Nationwide, prescriptions for psychotropic drugs increased dramatically between 1985 and 1994.
Nationwide, prescriptions for psychotropic drugs increased dramatically between 1985 and 1994.
The upturn in prescriptions has been spurred by the new generation of drugs like Prozac, researchers have found.
"There has been an enormous increase in research on mental disorders that has elaborated a much better understanding of how they come about and how to treat them more effectively," said Harold A. Pincus, M.D. Pincus is lead author of a new study in the Feb. 18 issue of The Journal of the American Medical Association.
Psychotropic medications-medications that have an effect on the mind-are among the most widely prescribed medications in the United States. As a class, they represented 8.8% of the prescription drug market in 1994, and their use has been increasing in recent years, according to information cited in the study.
Visits where depression was diagnosed almost doubled over the 10 years, from about 11 million to more than 20.4 million, researchers said.
More growth occurred in the prescribing of antidepressants than in any other category, from 30.4% to 45.2% of all psychotropic drugs, the researchers said. At the same time, tranquilizer prescriptions fell from 51.7% to 33%.
The researchers suggest that the structure of health care delivery and health care reimbursement may also be affecting the use of psychotropic drugs: "In many managed care organizations, the incentives of a capitated system would encourage primary care physicians to maintain responsibility for their patients with mental disorders, treat them efficiently with medications, and not refer them for specialty care."
In recent years, health officials have encouraged more recognition and drug treatment of depression, and campaigns have been waged to increase public and physician awareness of its prevalence.
However, there has also been a loud public outcry against using such drugs in nursing homes. Psychotropic medications and other prescriptions are often administered inappropriately in facilities, according to the Department of Health and Human Services.
In fact, nearly half of the nursing home pharmacists surveyed by department investigators indicated that residents receive medications that are not appropriate. PR
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.